Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.355
-0.021 (-5.53%)
At close: Dec 20, 2024, 4:00 PM
0.350
-0.005 (-1.44%)
After-hours: Dec 20, 2024, 7:57 PM EST
Oragenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | 0.04 | 0.13 | 0.09 | - | - | |
| Revenue Growth (YoY) | - | -71.37% | 51.20% | - | - | - | |
| Cost of Revenue | 13.49 | 15.49 | 10.07 | 10.59 | 22.11 | - | |
| Gross Profit | -13.49 | -15.45 | -9.94 | -10.5 | -22.11 | - | |
| Selling, General & Admin | 6.51 | 5.45 | 4.48 | 5.27 | 4.53 | 3.76 | |
| Research & Development | - | - | - | - | - | 12.12 | |
| Other Operating Expenses | - | - | - | 0 | 0 | 0 | |
| Operating Expenses | 6.51 | 5.45 | 4.48 | 5.27 | 4.54 | 15.88 | |
| Operating Income | -20 | -20.9 | -14.42 | -15.77 | -26.64 | -15.88 | |
| Interest Expense | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Interest & Investment Income | 0.07 | 0.21 | 0.14 | 0.08 | 0.09 | 0.32 | |
| Other Non Operating Income (Expenses) | 0.02 | 0.07 | 0.01 | 0 | 0 | 0 | |
| EBT Excluding Unusual Items | -19.97 | -20.66 | -14.29 | -15.71 | -26.56 | -15.57 | |
| Other Unusual Items | - | - | - | - | 0.13 | - | |
| Pretax Income | -19.97 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | |
| Earnings From Continuing Operations | -19.97 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | |
| Net Income | -19.97 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | |
| Net Income to Common | -19.97 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | |
| Shares Outstanding (Basic) | 4 | 2 | 2 | 2 | 1 | 1 | |
| Shares Outstanding (Diluted) | 4 | 2 | 2 | 2 | 1 | 1 | |
| Shares Change (YoY) | 99.08% | 11.97% | 3.40% | 106.24% | 33.69% | 224.29% | |
| EPS (Basic) | -4.65 | -9.18 | -7.11 | -8.09 | -28.05 | -22.09 | |
| EPS (Diluted) | -4.65 | -9.18 | -7.11 | -8.09 | -28.05 | -22.09 | |
| Free Cash Flow | -7.68 | -7.29 | -15.36 | -13.51 | -16.95 | -13.04 | |
| Free Cash Flow Per Share | -1.79 | -3.24 | -7.64 | -6.95 | -17.99 | -18.50 | |
| Operating Margin | - | -55519.89% | -10964.61% | -18131.88% | - | - | |
| Profit Margin | - | -54858.14% | -10863.96% | -18062.03% | - | - | |
| Free Cash Flow Margin | - | -19363.34% | -11675.70% | -15535.76% | - | - | |
| EBITDA | -19.98 | -20.88 | -14.38 | -15.73 | -26.59 | -15.82 | |
| D&A For EBITDA | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | |
| EBIT | -20 | -20.9 | -14.42 | -15.77 | -26.64 | -15.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.